SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Amendment No. 1
Under the Securities Exchange Act of 1934
ADVANCED MEDICAL PRODUCTS, INC.
(Name of Issuer)
Common Stock, $.01 par value
Class A Preferred Stock
(Title of Class of Securities)
00753W 20 7
(CUSIP Number)
George L. Down
6 Woodcross Drive
Columbia, South Carolina 29212
(803) 407-3044
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 15, 1998
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this Schedule
13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4),
check the following box [ ].
4. SOURCE OF FUNDS
None (Carolina Medical, Inc. exchanged 200,000 shares of its common
stock for 300,000 shares of the common stock and 2,217 shares
of the Class A (nonvoting) Preferred Stock of Advanced Medical
Products, Inc. owned by Nishimoto Sangyo Company, Ltd.)
7. NUMBER OF SHARES BENEFICIALLY OWNED BY EACH
REPORTING PERSON WITH:
SOLE VOTING POWER
3,300,000 Common Stock
9. SOLE DISPOSITIVE POWER
3,300,000 Common Stock
2,217 Class A Preferred Stock
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
3,300,000
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
55.3%
Item 1. Security and Issuer.
This Schedule 13D is filed on behalf of Carolina Medical, Inc. (the
Reporting Entity), relative to the $ .01 par value common stock and the Class
A (nonvoting) Preferred Stock issued by Advanced Medical Products, Inc. (AMP).
The principal executive offices of AMP are located at 6 Woodcross Drive,
Columbia, South Carolina 29212.
Item 3. Source and Amount of Funds or Other Consideration.
The Reporting Company acquired 300,000 shares of common stock and 2,217
shares of Class A (nonvoting) Preferred Stock of AMP (the Shares) on May 15,
1998, as a result of a share exchange with Nishimoto Sangyo Company, Ltd.
(Nishimoto) in which Nishimoto acquired 200,000 shares of the common stock of
the Reporting Company (the Exchange).
Item 4. Purpose of the Transaction.
The Exchange was effected in order to eliminate ownership of the
Class A Preferred Stock by a third party and to facilitate AMPs ability
to raise capital. The Reporting Entity intends to review continuously
its investment in AMP and, on the basis of such review and such market
and other factors as it may deem relevant, may sell the Shares or acquire
additional shares of AMPs common stock.
The Reporting Entity is a party to a pending Share Exchange
Agreement with Biosensor Corporation (Biosensor) after which the
Reporting Entity will be a wholly owned subsidiary of Biosensor. There
is a proposal which is not yet binding in which a newly formed wholly
owned subsidiary of Biosensor would be merged through a reverse
triangular merger into AMP. AMP would survive the merger as a wholly
owned subsidiary of Biosensor and the Reporting Entitys ownership in AMP
would be eliminated.
Item 5. Interest in Securities of the Issuer.
(a) As of June 12, 1998, the Reporting Entity beneficially owned
3,300,000 shares (or approximately 55.3% of the outstanding
shares) of AMP common stock and 2,217 shares (or
approximately 93% of the outstanding shares) of AMP Class A
Preferred Stock.
(b) The Reporting Entity will have sole power to vote and to
dispose of the 3,300,000 common shares and sole power to
dispose of the 2,217 Class A Preferred shares.
(c) As of June 12, 1998, and within the last 60 days, to the best
knowledge and belief of the undersigned, other than as
described herein, no transactions involving AMP equity
securities had been engaged in by the Reporting Entity.
(d) No other person is known to have the right to receive or the
power to direct the receipt of dividends from, or the
proceeds from the sale of the Shares.
After reasonable inquiry and to the best knowledge and belief of
the undersigned, it is hereby certified that the information set forth
in this statement is true, complete and correct.
Dated: June 12, 1998 CAROLINA MEDICAL, INC.
s/s:__Ronald G.
Moye____________
Ronald
G. Moyer, Chief Executive Officer
F:\USERS\MO\MOYER\SCH-13D2.BIO
- - 1 -
